Key result
Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are effective in only 9% of infants and children.
Why the study?
Are guideline-recommended starting doses of adenosine effective in infants and children with supraventricular tachycardia?
Are guideline-recommended starting doses of adenosine effective in infants and children with supraventricular tachycardia?
Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are largely ineffective in pediatric patients.
Answers are grounded in this paper and cite their sources.
Guideline starting doses may be inadequate for most pediatric SVT; hypothesis-generating for dose optimization trials before any practice change.
This retrospective review of present practice of administration of adenosine by paediatricians shows that current guidelines recommend starting doses that are effective in only 9% of infants and children.
No takes yet. Share an insight, caveat, or question.
Jonathan Dixon (2005) studied this question. Current guideline-recommended starting doses of adenosine for supraventricular tachycardia are effective in only 9% of infants and children.
Synapse has enriched 10 related papers. Consider them for comparative context: